In Memoriam

In memoriam: Akira and Hideko Kaji

ASBMB Today Staff
Nov. 6, 2023

Akira and Hideko Katayama Kaji, a husband-and-wife research team that helped decipher the genetic code, died just months apart earlier this year. They had been members of the American Society for Biochemistry and Molecular Biology for decades.

Hideko Katayama Kaji, a longtime professor of pharmacology at Thomas Jefferson University and an ASBMB member since 1968, died on Jan. 18. She was 91.

This photo shows the Kajis at a lab reunion in 2019. It was posted on a public gallery, where you can see other photos.
This photo shows the Kajis at a lab reunion in 2019. It was posted on a public gallery, where you can see other photos.

Akira Kaji, a longtime professor of microbiology at the University of Pennsylvania and a member of the ASBMB since 1966, died May 13. He was 93.

Working together, Akira and Hideko Kaji discovered that transfer RNA binds to ribosomes in the presence of messenger RNA to help facilitate translation — a key to Marshall Nirenberg winning a Nobel Prize in 1968 for “the genetic code and its function in protein synthesis.” In his Nobel speech, Nirenberg said the Kajis’ findings provided the “clue to the solution” of how base composition within codons specifies each amino acid.

Akira Kaji was born on Jan. 13, 1930, in Tokyo, Japan. He earned a bachelor’s degree at the University of Tokyo in 1953, then received a Fulbright Scholarship and earned his Ph.D. at the McCollum Pratt Institute of Johns Hopkins University in 1958. In 1963, he joined the faculty of what became the Perelman School of Medicine at UPenn. The next year, he became an associate professor, and in 1973, he became a full professor.

In the early days of molecular biology, Akira Kaji studied protein synthesis and earned a Guggenheim fellowship to support this work. He discovered that dedicated machinery was required to terminate translation and recycle ribosomes from mRNA and contributed to studies of tRNA binding to translation complexes and the functional outcomes. He obtained the first patent for the use of an antisense oligonucleotide for the control of Herpes virus pathological effects.

Hideko Kaji was also born in Tokyo, on Jan. 1, 1932.  She earned a bachelor’s degree at the Tokyo College of Pharmacy in 1954, a master’s from the University of Nebraska in 1956 and a Ph.D. from Purdue University in 1958. She was a postdoc at Johns Hopkins School of Medicine and the Oak Ridge National Laboratory and later held positions at Vanderbilt University and the Institute for Cancer Research in Philadelphia, which later became the Fox Chase Cancer Center, before joining the faculty of Jefferson Medical College in 1976. She became a full professor of biochemistry and molecular pharmacology in 1983 and remained on the faculty for 45 years.

She discovered specific tRNA binding to mRNA-ribosome complexes, N-terminal protein modification by arginine and ribosome recycling in eukaryotes, the last step of protein synthesis.

The Kajis both enjoyed swimming and snorkeling. Akira Kaji was an ice hockey player in his youth and later took up ice dancing.

They are survived by two sons, Kenneth Kaji and Eugene Kaji, and two daughters, Naomi Shodhan and Amy Kaji.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
ASBMB Today Staff

This article was written by a member or members of the ASBMB Today staff.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in People

People highlights or most popular articles

Fliesler wins scientific and ethical awards
Member News

Fliesler wins scientific and ethical awards

July 21, 2025

He is being honored by the University at Buffalo and the American Oil Chemists' Society for his scientific achievements and ethical integrity.

Hope for a cure hangs on research
Essay

Hope for a cure hangs on research

July 17, 2025

Amid drastic proposed cuts to biomedical research, rare disease families like Hailey Adkisson’s fight for survival and hope. Without funding, science can’t “catch up” to help the patients who need it most.

Before we’ve lost what we can’t rebuild: Hope for prion disease
Feature

Before we’ve lost what we can’t rebuild: Hope for prion disease

July 15, 2025

Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal — and just getting started.

ASBMB members recognized as Allen investigators
Member News

ASBMB members recognized as Allen investigators

July 14, 2025

Ileana Cristea, Sarah Cohen, Itay Budin and Christopher Obara are among 14 researchers selected as Allen Distinguished Investigators by the Paul G. Allen Family Foundation.

AI can be an asset, ASBMB educators say
Advice

AI can be an asset, ASBMB educators say

July 9, 2025

Pedagogy experts share how they use artificial intelligence to save time, increase accessibility and prepare students for a changing world.

ASBMB undergraduate education programs foster tomorrow’s scientific minds
Feature

ASBMB undergraduate education programs foster tomorrow’s scientific minds

July 8, 2025

Learn how the society empowers educators and the next generation of scientists through community as well as accreditation and professional development programs that support evidence-based teaching and inclusive pedagogy.